rs2130262

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_182961.4(SYNE1):​c.12607G>A​(p.Glu4203Lys) variant causes a missense change. The variant allele was found at a frequency of 0.00483 in 1,614,080 control chromosomes in the GnomAD database, including 315 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another nucleotide change resulting in the same amino acid substitution has been previously reported as Likely benign in ClinVar. Synonymous variant affecting the same amino acid position (i.e. E4203E) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.026 ( 163 hom., cov: 32)
Exomes 𝑓: 0.0026 ( 152 hom. )

Consequence

SYNE1
NM_182961.4 missense

Scores

2
15

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:8

Conservation

PhyloP100: 6.50

Publications

8 publications found
Variant links:
Genes affected
SYNE1 (HGNC:17089): (spectrin repeat containing nuclear envelope protein 1) This gene encodes a spectrin repeat containing protein expressed in skeletal and smooth muscle, and peripheral blood lymphocytes, that localizes to the nuclear membrane. Mutations in this gene have been associated with autosomal recessive spinocerebellar ataxia 8, also referred to as autosomal recessive cerebellar ataxia type 1 or recessive ataxia of Beauce. Alternatively spliced transcript variants encoding different isoforms have been described. [provided by RefSeq, Jul 2008]
SYNE1 Gene-Disease associations (from GenCC):
  • autosomal recessive ataxia, Beauce type
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Laboratory for Molecular Medicine, Ambry Genetics, Orphanet, PanelApp Australia, G2P
  • Emery-Dreifuss muscular dystrophy 4, autosomal dominant
    Inheritance: AD Classification: STRONG, MODERATE, LIMITED Submitted by: Illumina, Ambry Genetics, PanelApp Australia, Labcorp Genetics (formerly Invitae)
  • arthrogryposis multiplex congenita 3, myogenic type
    Inheritance: AR Classification: STRONG, MODERATE Submitted by: PanelApp Australia, Labcorp Genetics (formerly Invitae)
  • autosomal dominant Emery-Dreifuss muscular dystrophy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • autosomal recessive myogenic arthrogryposis multiplex congenita
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0017381608).
BP6
Variant 6-152334195-C-T is Benign according to our data. Variant chr6-152334195-C-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 130402.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0865 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_182961.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SYNE1
NM_182961.4
MANE Select
c.12607G>Ap.Glu4203Lys
missense
Exon 77 of 146NP_892006.3Q8NF91-1
SYNE1
NM_033071.5
c.12394G>Ap.Glu4132Lys
missense
Exon 76 of 146NP_149062.2Q8NF91-4

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SYNE1
ENST00000367255.10
TSL:1 MANE Select
c.12607G>Ap.Glu4203Lys
missense
Exon 77 of 146ENSP00000356224.5Q8NF91-1
SYNE1
ENST00000423061.6
TSL:1
c.12394G>Ap.Glu4132Lys
missense
Exon 76 of 146ENSP00000396024.1A0A0C4DG40
SYNE1
ENST00000490135.6
TSL:1
n.-48G>A
upstream_gene
N/A

Frequencies

GnomAD3 genomes
AF:
0.0261
AC:
3973
AN:
152134
Hom.:
164
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0889
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0149
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000414
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000250
Gnomad OTH
AF:
0.0215
GnomAD2 exomes
AF:
0.00684
AC:
1718
AN:
251284
AF XY:
0.00506
show subpopulations
Gnomad AFR exome
AF:
0.0927
Gnomad AMR exome
AF:
0.00439
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000229
Gnomad OTH exome
AF:
0.00359
GnomAD4 exome
AF:
0.00261
AC:
3816
AN:
1461828
Hom.:
152
Cov.:
31
AF XY:
0.00230
AC XY:
1671
AN XY:
727212
show subpopulations
African (AFR)
AF:
0.0877
AC:
2936
AN:
33474
American (AMR)
AF:
0.00593
AC:
265
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26134
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39696
South Asian (SAS)
AF:
0.000278
AC:
24
AN:
86256
European-Finnish (FIN)
AF:
0.0000375
AC:
2
AN:
53382
Middle Eastern (MID)
AF:
0.00329
AC:
19
AN:
5768
European-Non Finnish (NFE)
AF:
0.000168
AC:
187
AN:
1112000
Other (OTH)
AF:
0.00634
AC:
383
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.488
Heterozygous variant carriers
0
201
402
602
803
1004
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
94
188
282
376
470
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0262
AC:
3983
AN:
152252
Hom.:
163
Cov.:
32
AF XY:
0.0254
AC XY:
1891
AN XY:
74432
show subpopulations
African (AFR)
AF:
0.0889
AC:
3692
AN:
41548
American (AMR)
AF:
0.0149
AC:
227
AN:
15270
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5192
South Asian (SAS)
AF:
0.000415
AC:
2
AN:
4824
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10608
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000250
AC:
17
AN:
68020
Other (OTH)
AF:
0.0213
AC:
45
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
188
376
564
752
940
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
42
84
126
168
210
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0106
Hom.:
127
Bravo
AF:
0.0303
TwinsUK
AF:
0.000809
AC:
3
ALSPAC
AF:
0.000778
AC:
3
ESP6500AA
AF:
0.0772
AC:
340
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.00844
AC:
1025
Asia WGS
AF:
0.00260
AC:
9
AN:
3478
EpiCase
AF:
0.000273
EpiControl
AF:
0.000415

ClinVar

ClinVar submissions
Significance:Benign/Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
3
not specified (3)
-
-
2
not provided (2)
-
-
1
Autosomal recessive ataxia, Beauce type (1)
-
-
1
Autosomal recessive ataxia, Beauce type;C2751807:Emery-Dreifuss muscular dystrophy 4, autosomal dominant (1)
-
-
1
Emery-Dreifuss muscular dystrophy 4, autosomal dominant (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.077
BayesDel_addAF
Benign
-0.60
T
BayesDel_noAF
Benign
-0.57
CADD
Benign
18
DANN
Benign
0.66
DEOGEN2
Benign
0.18
T
Eigen
Benign
-0.65
Eigen_PC
Benign
-0.42
FATHMM_MKL
Uncertain
0.95
D
LIST_S2
Uncertain
0.92
D
MetaRNN
Benign
0.0017
T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
-0.55
N
PhyloP100
6.5
PrimateAI
Benign
0.36
T
PROVEAN
Benign
-0.78
N
REVEL
Benign
0.15
Sift
Benign
0.21
T
Sift4G
Benign
0.35
T
Polyphen
0.0
B
Vest4
0.19
MVP
0.32
MPC
0.15
ClinPred
0.016
T
GERP RS
4.8
Varity_R
0.095
gMVP
0.14
Mutation Taster
=96/4
polymorphism (auto)

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2130262; hg19: chr6-152655330; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.